Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Jinan
Clinical trial register · China

Clinical Trials in Jinan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 1 Fujian 1 Guangzhou 1 Hunan 1 Jinan 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Qilu Hospital of Shandong University114 Qianfoshan Hospital31 Shandong Cancer Hospital and Institute30 AstraZeneca28 Shandong University25 Eli Lilly and Company24 Shandong Provincial Hospital15 The Second Hospital of Shandong University13 Hoffmann-La Roche13 Jiangsu Simcere Pharmaceutical Co., Ltd.10 Janssen Research & Development, LLC8 Sanofi8 Li Min7 GlaxoSmithKline7 Amgen7 Novartis Pharmaceuticals6 Jiangsu HengRui Medicine Co., Ltd.6 Institute of Hematology & Blood Diseases Hospital, China6 Daiichi Sankyo6 Changchun GeneScience Pharmaceutical Co., Ltd.6 Shanghai Henlius Biotech5 Suzhou Suncadia Biopharmaceuticals Co., Ltd.5 Alexion Pharmaceuticals, Inc.5 Akeso5 Sichuan Baili Pharmaceutical Co., Ltd.5 Shandong First Medical University4 Second Affiliated Hospital, Zhejiang University, School of Medicine4 Qilu Pharmaceutical Co., Ltd.4 Shanghai Jiaolian Drug Research and Development Co., Ltd4 Nanjing Leads Biolabs Co.,Ltd4 Yongtao Sun4 Fudan University4 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.4 Biotheus Inc.4 Shanghai Huaota Biopharmaceutical Co., Ltd.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4 BioNTech SE4 Xijing Hospital3 Lei ZHAO3 Dizal Pharmaceuticals3 Jinan Central Hospital3 Ruijin Hospital3 Hutchmed3 Bristol-Myers Squibb3 Suxia Li3 RemeGen Co., Ltd.3 Yipeng Liu3 Nanfang Hospital, Southern Medical University3 Sichuan Huiyu Pharmaceutical Co., Ltd3 Shanghai Junshi Bioscience Co., Ltd.3 Man Hu3 Fujian Shengdi Pharmaceutical Co., Ltd.3 Xiaorong Sun3 Pfizer3 Innovent Biologics (Suzhou) Co. Ltd.3 Boehringer Ingelheim3 Shandong Tumor Hospital2 Beijing QL Biopharmaceutical Co.,Ltd2 Otsuka Pharmaceutical Development & Commercialization, Inc.2 Tongji Hospital2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2 China Academy of Chinese Medical Sciences2 Hangzhou Endonom Medtech Co., Ltd.2 Beijing Pins Medical Co., Ltd2 Ding Ma2 Haiyan Wang2 Jacobio Pharmaceuticals Co., Ltd.2 Beihua Kong2 Huashan Hospital2 Peking University First Hospital2 Beijing Biostar Pharmaceuticals Co., Ltd.2 Johnson & Johnson Enterprise Innovation Inc.2 Eikon Therapeutics2 Genzyme, a Sanofi Company2 Shandong University of Traditional Chinese Medicine2 Tianjin Medical University Cancer Institute and Hospital2 BeOne Medicines2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 Lifetech Scientific (Shenzhen) Co., Ltd.2 Juventas Cell Therapy Ltd.2 Xu Liu2 Hangzhou Gensciences Biopharmaceutical Co., Ltd.2 Henan Genuine Biotech Co., Ltd.2 Eisai Inc.2 Shanghai Pulmonary Hospital, Shanghai, China2 Gilead Sciences2 UCB Biopharma SRL2 Shanghai RAAS Blood Products Co., Ltd.2 Jianbo Wu2 Novo Nordisk A/S2 Yueyue Li2 Takeda2 Xiuli Zuo2 Liu Yang2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Guangzhou Virotech Pharmaceutical Co., Ltd.2 Eye & ENT Hospital of Fudan University2 TransThera Sciences (Nanjing), Inc.2 Peking Union Medical College Hospital2 Beijing Tiantan Hospital2 Jiangsu Hansoh Pharmaceutical Co., Ltd.2 First Affiliated Hospital of Zhejiang University2 Jinbo Yue2 Shanghai Chest Hospital2 Adcentrx Therapeutics1 Dimerix Bioscience Pty Ltd1 Sichuan University1 Shanghai AbelZeta Ltd.1 Atom Therapeutics Co., Ltd1 The Children's Hospital of Zhejiang University School of Medicine1 Second Affiliated Hospital of Nanchang University1 Fujian Cancer Hospital1 Nuvation Bio Inc.1 Xiuping Ding1 Peking University1 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 Xiyuan Hospital of China Academy of Chinese Medical Sciences1 Gracell Biotechnologies (Shanghai) Co., Ltd.1 C Ray Therapeutics1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 Sinocelltech Ltd.1 Peking University People's Hospital1 Acerand Therapeutics (Shanghai) Limited1 FBD Biologics Limited1 Innolake Biopharm1 4D Molecular Therapeutics1 Xingshun Qi1 Genentech, Inc.1 Beijing Friendship Hospital1 Genuine Seed Therapeutics (Zhuhai) Co., Ltd.1 Hangzhou Sumgen Biotech Co., Ltd.1 MSD R&D (China) Co., Ltd.1 Pulnovo Medical, Inc.1 Wayshine Biopharm, Inc.1 Beeline Medicines Corporation1 Shanghai Shengdi Pharmaceutical Co., Ltd1 Betta Pharmaceuticals Co., Ltd.1 Avistone Biotechnology Co., Ltd.1 Jianmin Pharmaceutical Group Co., LTD.1 Heronova Pharmaceuticals1 Bayer1 Avenzo Therapeutics, Inc.1 Gan Lijun1 Fang Tang1 argenx1 Ton-Bridge Medical Tech. Co., Ltd1 Institut de Recherches Internationales Servier1 First Affiliated Hospital Xi'an Jiaotong University1 Cascade Pharmaceuticals, Inc1 Qinhuangdao Hospital of Traditional Chinese Medicine1 Biosense Webster, Inc.1 PersonGen BioTherapeutics (Suzhou) Co., Ltd.1 LEO Pharma1 Sinocare1 Genrix (Shanghai) Biopharmaceutical Co., Ltd.1 Beijing InnoCare Pharma Tech Co., Ltd.1 Hai Feng1 DualityBio Inc.1 GrandPharma (China) Co., Ltd.1 PharmaEssentia1 Xuanwu Hospital, Beijing1 Acerta Pharma BV1 Shanghai United Cell Biotechnology Co., Ltd1 Fortvita Biologics (USA)Inc.1 Sunshine Lake Pharma Co., Ltd.1 SUNHO(China)BioPharmaceutical CO., Ltd.1 Qurgen Inc.1 Yi Shuhua1 Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1 Bambusa Therapeutics1 Elpiscience (Suzhou) Biopharma, Ltd.1 Xiangya Hospital of Central South University1 Zhongda Hospital1 Fujian Medical University Union Hospital1 Suzhou Abogen Biosciences Co., Ltd.1 Zhejiang Yangli Pharmaceutical Technology Co., Ltd.1 Genfleet Therapeutics (Shanghai) Inc.1 InxMed (Shanghai) Co., Ltd.1 Shanghai Escugen Biotechnology Co., Ltd1 MAXVAX Biotechnology Limited Liability Company1 RenJi Hospital1 First Affiliated Hospital of Wenzhou Medical University1 Wen-hong Zhang1 Xizang Haisco Pharmaceutical Co., Ltd1 Su Guohai1 First People's Hospital of Hangzhou1 Shanghai University of Traditional Chinese Medicine1 Nanjing IASO Biotechnology Co., Ltd.1 Merck Sharp & Dohme LLC1 Sinovac Life Sciences Co., Ltd.1 Vividion Therapeutics, Inc.1 Xueyan Cui1 The First Affiliated Hospital of Zhengzhou University1 Teligene US1 Hangzhou DAC Biotechnology Co., Ltd.1 Feng Tian1 Guangzhou Excelmab Inc.1 Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.1 Children's Hospital of Fudan University1 University of Texas at Austin1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 Peking University Third Hospital1 Zhejiang Cancer Hospital1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Edwards Lifesciences1 Beijing Kanghong Biopharmaceutical Co., Ltd.1 Mainline Biosciences (Shanghai) Co., Ltd1 Yanqing Li1 Obstetrics & Gynecology Hospital of Fudan University1 Hunan Kelun Pharmaceutical Co., Ltd.1 Servier Bio-Innovation LLC1 Haisco Pharmaceutical Group Co., Ltd.1 Yang Xiaodong1 Astellas Pharma Global Development, Inc.1 Climb Bio, Inc.1 Wei Zhao1 Seagen, a wholly owned subsidiary of Pfizer1 Bioverativ, a Sanofi company1 InnovStone Therapeutics Limited1 CASI pharmaceuticals, Inc.1 Chipscreen Biosciences, Ltd.1 Philips Clinical & Medical Affairs Global1 WestVac Biopharma Co., Ltd.1 Beijing 302 Hospital1 HaoxuanZhang1 Tavotek Biotherapeutics1 Bei Wang1 Beijing University of Chinese Medicine1 Qinghai Red Cross Hospital1 The First Affiliated Hospital with Nanjing Medical University1 Shanghai Hengrui Pharmaceutical Co., Ltd.1 Chen Xiaoping1 Jazz Pharmaceuticals1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1 Shanghai Zhongshan Hospital1 Huabo Biopharm Co., Ltd.1 National Cancer Centre, Singapore1 China Medical University, China1 Pingping Song1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Shanghai Best-Link Bioscience, LLC1 Evopoint Biosciences Inc.1 Excyte Biopharma Ltd1 Newish Biotech (Wuxi) Co., Ltd.1 Colorado Prevention Center1 Mirati Therapeutics Inc.1 Jingbo Chen1 Genmab1 NextCure, Inc.1 Guangdong Hengrui Pharmaceutical Co., Ltd1 The University of Hong Kong1 Xinrui Zhang1 Grand Theravac Life Sciences (Nanjing) Co., Ltd.1 LI YAN1 Jun Zhou1 Shanghai Ming Ju Biotechnology Co., Ltd.1 Zunsong Wang1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 First Affiliated Hospital of Wannan Medical College1 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1 Southeast University, China1 Suzhou Forlong Biotechnology Co., Ltd1 Antengene Biologics Limited1 AbbVie1 Hairong Chen1 Hao Feng1 Boston Scientific Corporation1 Shanghai Jiao Tong University School of Medicine1 Henan University of Traditional Chinese Medicine1 Taiho Oncology, Inc.1 Women's Hospital School Of Medicine Zhejiang University1 China-Japan Friendship Hospital1 Shandong Public Health Clinical Center1 Xiaolu Li1 Zai Lab (Shanghai) Co., Ltd.1 Lepu Biopharma Co., Ltd.1 Huahui Health1 Hua Zhang1 Latticon Antibody Therapeutics, Inc1 Abbisko Therapeutics Co, Ltd1 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.1 MediLink Therapeutics (Suzhou) Co., Ltd.1 Shandong Suncadia Medicine Co., Ltd.1 Pengfei Qiu1 Xuanzhu Biopharmaceutical Co., Ltd.1 Staidson (Beijing) Biopharmaceuticals Co., Ltd1 Abbott Medical Devices1 Santen Pharmaceutical Co., Ltd.1 Guangdong Raynovent Biotech Co., Ltd1 Zhang Jianguo1 Dou Fulin1 Ipsen1 Shanghai Mianyi Biopharmaceutical Co., Ltd.1 Clear sponsor filter
Site location
Beijing1 Fujian1 Guangzhou1 Hunan1 Jinan1 Shanghai1 Wuhan1
All 7 locations
Target enrolment
to

Trials with a site in Jinan

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
A Study of ADRX-0706 in Select Advanced Solid Tumors
NCT06036121Solid Tumors, Triple Negative Breast Cancer (TNBC), Urothelial Cancer, Cervical Cancer
Adcentrx Therapeutics
Phase 1
144
Beijing, Fujian, Guangzhou, Hunan, Jinan, Shanghai, Wuhan
2023-09-26
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/jinan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Jinan that also match the filters currently applied.

How many clinical trials are recruiting in Jinan?

0 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jinan), 1 studies
PhaseStudiesRecruitingShare
Phase 110100%

Most active sponsors

Lead sponsors with the most studies (Jinan)
Lead sponsorStudiesRecruiting
Adcentrx Therapeutics10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.